R&D News ......................... 1
Appointments .................... 6
Pharma Notes .................... 7
New Products .................. 16
Calendar .......................... 17
App Reviews ..................... 18
P h a r m a c e u t i c a l c l i n i c a l c h e m i c a l f o o d e n v i r o n m e n t
w w w . l a b o r a t o r y f o c u s . c a
august/sePtember 2016 volume 20, number 3
Publications Mail Registration Number: 40052410
canada invests in Poultry anti-microbial develoPment
MISSISSAUGA, ON – A Canadian
biotechnology company has been
awarded a $3.4 million government
investment to help develop a new
line of anti-microbial feed additives
to help control disease outbreaks in
poultry flocks
AbCelex, which focuses on de-
veloping livestock food additives
that help improve animal health
and food safety, is developing a
line of innovative non-antibiotic,
non-hormonal additives that are
specifically targeted at Campylo-
bacter and Salmonella, two of the
most common food-borne bacteria
that infect poultry.
healthier Poultry
The new anti-microbials – called
When Work hurts:
taking the pain
out of the job
Page 8
emerging in vivo
electrophysiology
methods in
neuroscience research
Page 10
Photo
Credit:
OBIO
'nanobodies' – will result in healthi-
er poultry and improve food safety.
The project will be conducted in
collaboration with the International
Vaccine Centre at the University
of Saskatchewan, the University
of Toronto and Colorado Quality
Research Inc.
Funding for the project comes
from the AgriInnovation Program
(Research and Development
Stream) as part of the Growing
Forward 2 agricultural policy frame-
work.
reducing the use of antibiotics
"These innovations will reduce
the use of antibiotics and result in
safer food, a healthier population
and a more productive agricultural
economy," stated Navdeep Bains,
Minister of Innovation, Science and
Economic Development.
Dr. Saeid Babaei, president and
CEO of AbCelex Technologies
added his company is appreciative
of the funding.
"With this visionary contribution
and other strategic investments,
AbCelex Technologies is well po-
sitioned to advance its platform
technology and develop next-
generation biological products
needed for improved human health
and a reduction in healthcare costs
as a result of food contamination,"
he said.
To see this story online visit
http://www.laboratoryfocus.ca/
canada-invests-in-poultry-anti-
microbial-development/
